“CAR-T-Cell Therapy treats three autoimmune diseases in the same person.”
Views expressed in this science, space, and technology update are those of the reporters and correspondents. Accessed on 10 April 2026, 1618 UTC.
Content and Source: “Nature Briefing.”
https://mail.google.com/mail/u/0/#inbox/FMfcgzQgLPJxnLDztHlVkjFJTBqMsXWR
URL–https://www.nature.com.
Please check email link, URL, or scroll down to read your selections.
|
||||||||
|
||||||||
|
Hello Nature readers, |
||||||||
![]() |
||||||||
| CAR-T therapy is typically used to treat blood cancers such as leukaemia, and it remains experimental for autoimmune conditions. (Ruslanas Baranauskas/Science Photo Library) | ||||||||
One CAR-T to cure them allA woman with an ultra-rare combination of three autoimmune diseases has had no symptoms since receiving a single dose of engineered immune cells. Researchers used the woman’s own T cells to develop chimeric antigen receptor (CAR) T cells that targeted a protein on her B cells — the culprits behind her trifecta of autoimmune conditions. The woman experienced no side effects from the treatment, and fourteen months on she doesn’t take any medication for her conditions, says haematologist Fabian Müller, who helped to develop the treatment. Nature | 5 min read |
||||||||
|
||||||||
Misconduct database divides researchersA US database of people found guilty of academic misconduct or workplace harassment could prevent such individuals from securing jobs at new universities without disclosing their bad behaviour, a Science editorial suggests. Such a measure is necessary to “make it much more difficult for offending scientists to evade accountability”, says Michael Lauer, a former official at the US National Institutes of Health and one of the editorial’s authors. But researchers who spoke to Nature are divided over whether this centralized, confidential list would solve the problem or generate new ones, such as the risk that the identities of witnesses could be compromised. Nature | 5 min read |
||||||||
Question of the weekWould you support the use of a database that would mandate that research institutions report instances of misconduct — be it personal or scientific — among their current staff, and check the histories of potential applicants before offering them a job?
|
||||||||
|
||||||||
|
||||||||
|
||||||||
‘Seeing what you’ve forgotten to notice’In her debut poetry collection, fisheries biologist Liz Renner chose to celebrate the organism she studied for her dissertation, the gizzard shad (Dorosoma cepedianum): O silver-bellied keeper of the lake,/ Whose schools like drifting coins revolve below —/ You rise where sunlight quivers into wake,/ And churn the silt where hidden stories flow. Renner is one of many scientists who told Nature why they write poetry, from explaining the complexities of their work to processing the difficulties they’ve faced in their careers. Writing poetry “slows you down”, says engineer and amateur poet Fionn Rogan. Poetry, he says, “is about looking seriously at the world and seeing what’s right in front of you, but you’ve forgotten to notice”. |
||||||||
Futures: Immolation‘The Extractor’ learns that some things can’t be bought in the latest short story for Nature’s Futures series. |
||||||||
Five best science books this weekAndrew Robinson’s pick of the top five science books to read this week includes an argument for art as the ‘fifth pillar of health’ and a deep dive into the language we use to describe the natural world. |
||||||||
Quote of the day“I realized I wasn’t laughing because it was absurd. I was laughing because it resonated.”An online Chinese-language game called Green Pepper Simulator gives players the opportunity to assume the role of an early-career researcher trying to survive six years in academia. The game hit a little too close to home for healthcare researcher Lingling Yuan when the “mental-health bar was falling faster than my publication count was rising”. (Nature | 6 min read) |
||||||||
|
|
||||||||
|
||||||||
|
|
||||||||
Free newsletters from NatureWant more? Update your preferences to sign up to our other Nature Briefing newsletters:
|
||||||||
|
||||||||
| You received this newsletter because you subscribed with the email address: kh6jrm@gmail.com
Please add briefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? To unsubscribe from this Briefing, but keep receiving your other Nature Briefing newsletters, please update your subscription preferences. To stop all Nature Briefing emails forever, click here to remove your personal data from our system. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Want to master time management, protect your mental health and brush up on your skills? Sign up for our free short e-mail series for working scientists, Back to the lab. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Portfolio journals. Would you like to read the Briefing in other languages? 关注Nature Portfolio官方微信订阅号,每周二为您推送Nature Briefing精选中文内容——自然每周简报。 Nature Portfolio | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Portfolio, part of Springer Nature. |



